Two Drugmakers Paid More Than a Quarter Million American Prescribers as Weight Loss Drug Sales Climbed
An analysis of federal payment data found Eli Lilly and Novo Nordisk paid over 250,000 US prescribers as GLP-1 weight loss drug sales grew.
Medical Daily ·